The Readout Loud

Episodes

• Episode 63: Your ASCO preview, genetic whiplash, and a journalist's experience with cancer

  May 23, 2019

  Not summarized yet

• Episode 62: Drug pricing partisanship, tech's march into health care, and Tinder for clinical trials

  May 16, 2019

  Not summarized yet

• Episode 61: Pharma felonies, cardiac CRISPR, and a strange day at the FDA

  May 9, 2019

  Not summarized yet

• Episode 60: Boardroom drama, whiskey-fueled science, & millionaires on mushrooms

  May 2, 2019

  Not summarized yet

• Episode 59: When scientists get mad online, for-profit cancer care, & the perils of naming a startup

  Apr 25, 2019

  Not summarized yet

• Episode 58: Democratizing CRISPR, drugging the undruggable, and reading pharma's fine print

  Apr 18, 2019

  Not summarized yet

• Episode 57: Trump’s drug pricing foot soldier, Gilead’s uncertain future, & transpacific angst

  Apr 11, 2019

  Not summarized yet

• Episode 56: Cheaper insulin, the next Juul, and diagnosing disease with sound

  Apr 4, 2019

  Not summarized yet

• Episode 55: The fate of Bristol-Myers-Celgene, the tragedy of SIDS, and health tech's challenges

  Mar 28, 2019

  Not summarized yet

• Episode 54: Another big Alzheimer’s failure, postpartum progress, and Long Island shores

  Mar 21, 2019

  Not summarized yet

• Episode 53: How startups stop, the new FDA boss, and Theranos on the big screen

  Mar 14, 2019

  Not summarized yet

• Episode 52: Every conceivable angle of Scott Gottlieb's FDA resignation

  Mar 7, 2019

  Not summarized yet

• Episode 51: CEOs at the Senate, merger mania, and sleuthing startups

  Feb 28, 2019

  Not summarized yet

• Episode 50: A big scoop on opioid marketing

  Feb 22, 2019

  Not summarized yet

• Episode 49: Painkiller racketeering, the limits of genetic tests, and pharma's day on the Hill

  Feb 21, 2019

  Not summarized yet

• Episode 48: The AI hype machine, ketamine's future, and the rocky path ahead for NASH

  Feb 14, 2019

  Not summarized yet

• Episode 47: A bad day for bold biotech, campaign 2020, and where do drugs come from?

  Feb 7, 2019

  Not summarized yet

• Episode 46: Another Alzheimer's setback, crypto for biotech, and a blessing of unicorns

  Jan 31, 2019

  Not summarized yet

• Episode 45: CRISPR upheaval, Celgene's chutzpah, and canine genomics

  Jan 24, 2019

  Not summarized yet

• Episode 44: FDA furloughs, '80s pop radio, and video game therapeutics

  Jan 17, 2019

  Not summarized yet